The Lobular Breast Cancer Alliance (LBCA) welcomed its newest Scientific Advisory Board (SAB) member Peter Simpson, PhD, in late 2021. Dr. Simpson is an associate professor at University of Queensland Centre for Clinical Research (UQCCR). He holds a joint teaching and research position where he is head of the Cancer Theme and is a research group leader at UQCCR.

Watch Dr. Simpson in this interview with LBCA Communications Director Colleen Fitzwater, and learn more about his team’s current invasive lobular carcinoma (ILC) research related to development of LobSig, a multigene predictor of outcome in ILC. He also talks about his reasons for joining the SAB and why he believes cross-continental and cross-lab collaboration is so important for lobular breast cancer research.

Interested in learning more about LobSig? Watch Dr. Simpson’s presentation at the 2021 International ILC Virtual Symposium. His presentation begins at 1:29:00.